Cognition Therapeutics
+$0.19 (+7.63%) Today
-$0.06 (-2.24%) As of 8:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.
About CGTX
Cognition Therapeutics, Inc. is a clinical stage neuroscience company. The firm develops drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.
CEO
Lisa R. Ricciardi
Employees
21
Headquarters
Purchase, New York
Founded
2007
CGTX Key Statistics
Market cap
60.56M
Price-Earnings ratio
—
Dividend yield
—
Average volume
22.77K
High today
$2.79
Low today
$2.49
Open price
$2.49
Volume
36.71K
52 Week high
$13.80
52 Week low
$2.31
CGTX Earnings
-$11.74
-$7.83
-$3.91
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market